Cargando…

Unique molecular signature in mucolipidosis type IV microglia

BACKGROUND: Lysosomal storage diseases (LSD) are a large family of inherited disorders characterized by abnormal endolysosomal accumulation of cellular material due to catabolic enzyme and transporter deficiencies. Depending on the affected metabolic pathway, LSD manifest with somatic or central ner...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cougnoux, Antony, Drummond, Rebecca A., Fellmeth, Mason, Navid, Fatemeh, Collar, Amanda L., Iben, James, Kulkarni, Ashok B., Pickel, James, Schiffmann, Raphael, Wassif, Christopher A., Cawley, Niamh X., Lionakis, Michail S., Porter, Forbes D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935239/ https://www.ncbi.nlm.nih.gov/pubmed/31883529 http://dx.doi.org/10.1186/s12974-019-1672-4

Ejemplares similares

Single Cell Transcriptome Analysis of Niemann–Pick Disease, Type C1 Cerebella
por: Cougnoux, Antony, et al.
Publicado: (2020)

Identification of Novel Pathways Associated with Patterned Cerebellar Purkinje Neuron Degeneration in Niemann-Pick Disease, Type C1
por: Martin, Kyle B., et al.
Publicado: (2019)

Abnormal LAMP1 glycosylation may play a role in Niemann-Pick disease, type C pathology
por: Cawley, Niamh X., et al.
Publicado: (2020)

The Dictyostelium Model for Mucolipidosis Type IV
por: Allan, Claire Y., et al.
Publicado: (2022)

Autophagic dysfunction in mucolipidosis type IV patients
por: Vergarajauregui, Silvia, et al.
Publicado: (2008)

Phenotype assessment for neurodegenerative murine models with ataxia and application to Niemann–Pick disease, type C1
por: Yerger, Julia, et al.
Publicado: (2022)

Evaluation of the Potential Role of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Niemann–Pick Disease, Type C1
por: Cawley, Niamh X., et al.
Publicado: (2020)

The first genetically confirmed Japanese patient with mucolipidosis type IV
por: Saijo, Harumi, et al.
Publicado: (2016)

Cross-sectional Observations on the Natural History of Mucolipidosis Type IV
por: Misko, Albert L., et al.
Publicado: (2022)

Peripheral Inflammatory Cytokine Signature Mirrors Motor Deficits in Mucolipidosis IV
por: Misko, Albert L., et al.
Publicado: (2022)

Systematic Screens for Proteins That Interact with the Mucolipidosis Type IV Protein TRPML1
por: Spooner, Ellen, et al.
Publicado: (2013)

Impaired myelination and reduced brain ferric iron in the mouse model of mucolipidosis IV
por: Grishchuk, Yulia, et al.
Publicado: (2015)

Early evidence of delayed oligodendrocyte maturation in the mouse model of mucolipidosis type IV
por: Mepyans, Molly, et al.
Publicado: (2020)

Neuropathophysiology, Genetic Profile, and Clinical Manifestation of Mucolipidosis IV—A Review and Case Series
por: Jezela-Stanek, Aleksandra, et al.
Publicado: (2020)

Neurologic Abnormalities in Mouse Models of the Lysosomal Storage Disorders Mucolipidosis II and Mucolipidosis III γ
por: Idol, Rachel A., et al.
Publicado: (2014)

Behavioral deficits, early gliosis, dysmyelination and synaptic dysfunction in a mouse model of mucolipidosis IV
por: Grishchuk, Yulia, et al.
Publicado: (2014)

The mucolipidosis IV Ca(2+) channel TRPML1 (MCOLN1) is regulated by the TOR kinase
por: Onyenwoke, Rob U., et al.
Publicado: (2015)

Correction: Neurologic Abnormalities in Mouse Models of the Lysosomal Storage Disorders Mucolipidosis II and Mucolipidosis III γ
Publicado: (2014)

Case Report: Mucolipidosis II and III Alpha/Beta Caused by Pathogenic Variants in the GNPTAB Gene (Mucolipidosis)
por: Mao, Shao-Jia, et al.
Publicado: (2022)

Probing pathomechanisms of mucolipidosis II in fish
Publicado: (2012)

Hip Morphology in Mucolipidosis Type II
por: Ammer, Luise Sophie, et al.
Publicado: (2020)

Complex N-Linked Glycosylation: A Potential Modifier of Niemann–Pick Disease, Type C1 Pathology
por: Cawley, Niamh X., et al.
Publicado: (2022)

Mucolipidosis Type IV in Omani Families with a Novel MCOLN1 Mutation: Search for Evidence of Founder Effect
por: Al-Alawi, Badriya, et al.
Publicado: (2022)

Differential Proteomics Reveals miR-155 as a Novel Indicator of Liver and Spleen Pathology in the Symptomatic Niemann-Pick Disease, Type C1 Mouse Model
por: Pergande, Melissa R., et al.
Publicado: (2019)

Membrane traffic and turnover in TRP-ML1–deficient cells: a revised model for mucolipidosis type IV pathogenesis
por: Miedel, Mark T., et al.
Publicado: (2008)

Proteomics analysis of a human brain sample from a mucolipidosis type IV patient reveals pathophysiological pathways
por: Vardi, Ayelet, et al.
Publicado: (2021)

TPC2 rescues lysosomal storage in mucolipidosis type IV, Niemann–Pick type C1, and Batten disease
por: Scotto Rosato, Anna, et al.
Publicado: (2022)

Brain cell type specific proteomics approach to discover pathological mechanisms in the childhood CNS disorder mucolipidosis type IV
por: Sangster, Madison, et al.
Publicado: (2023)

Mucolipidosis II: first report from Saudi Arabia
por: Alfadhel, Majid, et al.
Publicado: (2013)

Mucolipidosis type III, a series of adult patients
por: Oussoren, Esmee, et al.
Publicado: (2018)

Diagnosis of Mucopolysaccharidoses and Mucolipidosis by Assaying Multiplex Enzymes and Glycosaminoglycans
por: Arunkumar, Nivethitha, et al.
Publicado: (2021)

Mechanistic Insights into the Role of C-Type Lectin Receptor/CARD9 Signaling in Human Antifungal Immunity
por: Drummond, Rebecca A., et al.
Publicado: (2016)

Necroptosis in Niemann–Pick disease, type C1: a potential therapeutic target
por: Cougnoux, A, et al.
Publicado: (2016)

New targets for old diseases: lessons from mucolipidosis type II
por: Settembre, Carmine, et al.
Publicado: (2013)

Elevated Bone Turnover in an Infantile Patient with Mucolipidosis II; No Association with Hyperparathyroidism
por: Otomo, Takanobu, et al.
Publicado: (2011)

Mucolipidosis Type II Secondary to GNPTAB Gene Deletion from India
por: Gowda, Vykuntaraju K., et al.
Publicado: (2017)

Humoral immune response in adult Brazilian patients with Mucolipidosis III gamma
por: Sperb-Ludwig, Fernanda, et al.
Publicado: (2019)

Human CARD9: A Critical Molecule of Fungal Immune Surveillance
por: Drummond, Rebecca A., et al.
Publicado: (2018)

It’s all in your head: antifungal immunity in the brain
por: Snarr, Brendan D, et al.
Publicado: (2020)

Immune responses to human fungal pathogens and therapeutic prospects
por: Lionakis, Michail S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nqonsjkamh8obrgq1o2qq075tc